Compared with the control group, the SOD, MDA, and GSH-Px increased significantly in the model group and were effectively decreased after the administration of different doses of PPWE compared with the model group (p < 0.05 or p < 0.01), which indicates that PPWE alleviates dysmenorrhea by reducing uterine oxidative stress. Here, SOD1 is linked to Dysmenorrhea.